Evidence map›Paper›PMID 35996666›Full record

ArticlePeerJ2022

The blunted vascular endothelial growth factor-A (VEGF-A) response to high-altitude hypoxia and genetic variants in the promoter region of the

Yunden Droma, Masayuki Hanaoka, Takumi Kinjo, Nobumitsu Kobayashi, Masanori Yasuo, Yoshiaki Kitaguchi, Masao Ota

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 6 citations in OpenAlex.

  1. Sex- and age-specific associations ofAnnals of medicine · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. International journal of chronic obstructive pulmonary disease · 2026
    Article
  6. [Body Function Changes and Prevention Strategies in High-Altitude Environment].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2024
    Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yunden Droma *The First Department of Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Masayuki Hanaoka *The First Department of Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Takumi KinjoThe First Department of Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Nobumitsu KobayashiThe First Department of Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Masanori YasuoThe First Department of Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Yoshiaki KitaguchiThe First Department of Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Masao OtaDepartment of Medicine, Division of Hepatology and Gastroenterology, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Shinshu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Sherpa highlanders demonstrate extraordinary tolerance to hypoxia at high altitudes, which may be achieved by mechanisms promoting microcirculatory blood flow and capillary density at high altitudes for restoring oxygen supply to tissues. Vascular endothelial growth factors (VEGFs) are important signaling proteins involved in vasculogenesis and angiogenesis which are stimulated by hypoxia. We hypothesize that the VEGF-A, the major member of the VEGF family, and the gene encoding VEGF-A ( Methods: Fifty-one Sherpa highlanders in Namche Bazaar village at a high altitude of 3,440 meters (m) above sea level and 76 non-Sherpa lowlanders in Kathmandu city at 1,300 m in Nepal were recruited for the study. Venous blood was sampled to obtain plasma and extract DNA from each subject. The plasma VEGF-A concentrations were measured and five single-nucleotide polymorphisms (SNPs, rs699947, rs833061, rs1570360, rs2010963, and rs3025039) in the Results: A significant difference in oxygen saturation (SpO Conclusions: Sherpa highlanders exhibited a blunted VEGF-A response to hypoxia at high altitudes, which was speculated to be associated with the distinctive genetic variations of the SNPs and haplotype in the promoter region of

Indexed as

Altitude SicknessHumansHypoxiaMicrocirculationPromoter Regions, GeneticVascular Endothelial Growth Factor AVascular Endothelial Growth Factor AVEGFA protein, humanGenetic adaptationHigh altitudeHypoxiaSherpa highlandersVascular endothelial growth factor

Identifiers

PMID35996666
PMCPMC9392454
OpenAlexW4292314135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.